Literature DB >> 16650040

The role of probiotics in the management of allergic disease.

R J Boyle1, M L K Tang.   

Abstract

Probiotics have recently been advocated for the prevention and treatment of allergic disease (AD). In clinical practice they are increasingly being used for these purposes. Here we review the evidence base for the use of probiotics in the management of AD. We find support for their use in the treatment of childhood eczema, but the clinical significance of any treatment effect is uncertain. There is also evidence to support the use of probiotics in the prevention of childhood eczema. However the available evidence suggests that probiotics are not an effective treatment for allergic airway diseases. Probiotics may be more effective when used early in life, and they may have a particular role in gastrointestinal AD. The relative efficacy of different probiotic strains in the management of AD is not well established, and further work is needed to establish their mechanisms of action. In summary probiotics are likely to play a part in the management of childhood eczema in the future, and further studies are warranted to precisely define their role.

Entities:  

Mesh:

Year:  2006        PMID: 16650040     DOI: 10.1111/j.1365-2222.2006.02472.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  21 in total

Review 1.  Genes and molecules of lactobacilli supporting probiotic action.

Authors:  Sarah Lebeer; Jos Vanderleyden; Sigrid C J De Keersmaecker
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

2.  A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells.

Authors:  Shahram Lavasani; Balik Dzhambazov; Mehrnaz Nouri; Frida Fåk; Sophia Buske; Göran Molin; Henrik Thorlacius; Jan Alenfall; Bengt Jeppsson; Björn Weström
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

3.  Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study.

Authors:  John Penders; Carel Thijs; Piet A van den Brandt; Ischa Kummeling; Bianca Snijders; Foekje Stelma; Hanne Adams; Ronald van Ree; Ellen E Stobberingh
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

4.  Adaptation and Probiotic Potential of Lactobacilli, Isolated from the Oral Cavity and Intestines of Healthy People.

Authors:  Yulia Chervinets; Vyacheslav Chervinets; Boris Shenderov; Ekaterina Belyaeva; Andrey Troshin; Sergey Lebedev; Valery Danilenko
Journal:  Probiotics Antimicrob Proteins       Date:  2018-03       Impact factor: 4.609

5.  Intranasal bacteria induce Th1 but not Treg or Th2.

Authors:  M Costalonga; P P Cleary; L A Fischer; Z Zhao
Journal:  Mucosal Immunol       Date:  2008-10-08       Impact factor: 7.313

6.  Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications.

Authors:  M Medina; E Izquierdo; S Ennahar; Y Sanz
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

7.  Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults.

Authors:  Riina-A Kekkonen; Marko Sysi-Aho; Tuulikki Seppanen-Laakso; Ilkka Julkunen; Heikki Vapaatalo; Matej Oresic; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

8.  Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis.

Authors:  Alfonso Iovieno; Alessandro Lambiase; Marta Sacchetti; Barbara Stampachiacchiere; Alessandra Micera; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-11-27       Impact factor: 3.117

9.  Probiotic bacteria change Escherichia coli-induced gene expression in cultured colonocytes: Implications in intestinal pathophysiology.

Authors:  Pinaki Panigrahi; Gheorghe T Braileanu; Hegang Chen; O Colin Stine
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

10.  Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants.

Authors:  Odile Ménard; Marie-José Butel; Valérie Gaboriau-Routhiau; Anne-Judith Waligora-Dupriet
Journal:  Appl Environ Microbiol       Date:  2007-12-14       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.